SCHEMBL5671665

SCHEMBL5671665

O=C1[N]C2(CCN(C(=O)c3ccc4ccccc4c3)CC2)NC1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.51
DRD4 P21917 3/20 0.49
TSHR P16473 2/20 0.46
LMNA P02545 2/20 0.46
RAB9A P51151 1/20 0.46
ACHE P22303 1/20 0.45
HPGD P15428 1/20 0.45
AKR1C1 Q04828 1/20 0.44
MEN1 O00255 1/20 0.42
POLB P06746 1/20 0.42
KMT2A Q03164 1/20 0.42
CAPN1 P07384 1/20 0.42
CTSB P07858 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4003425 0.87 KMT2A (0.45) LMNAHPGDMEN1POLBKMT2A
SCHEMBL3999620 0.87 MAPK1 (0.46) TSHRLMNAHPGDMEN1POLB
SCHEMBL3997334 0.85 MGLL (0.47) TSHRHPGDMEN1KMT2AALDH1A1
SCHEMBL4001386 0.84 MEN1 (0.42) TSHRLMNAMEN1KMT2A
SCHEMBL5666405 0.83 CYP3A4 (0.58) LMNAHPGDPOLBUSP2ALDH1A1
SCHEMBL3997343 0.83 NAMPT (0.42) TSHRLMNAMEN1KMT2AUSP2
SCHEMBL4000176 0.82 CA1 (0.59) CA12CA1CA2CA7CA9
SCHEMBL5670552 0.82 AVPR1A (0.56) LMNAMEN1KMT2AALDH1A1
SCHEMBL5666367 0.81 ALDH1A1 (0.53) MEN1POLBKMT2AALDH1A1GAA
SCHEMBL1810855 0.81 NPC1 (0.52) NPC1DRD4TSHRLMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730147-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2006-12-13 EP disclosed
WO-2005095402-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2005-10-13 WO disclosed